王成 王成博士,副教授。主要从事生物医用纳米载体材料的构建与靶向给药系统的研究，主讲《药剂学》。以第一负责人主持完成国家自然科学基金、中国博士后科学基金、博后特别资助基金、山东省自然基金、中国海洋大学青年教师等多项基金，以第三负责人完成国家重大新药创制2项，并于2015年9月借调国家总局药品审评中心挂职工作一年，兼任山东省一致性评价技术专家委员会药物制剂组专家、青岛市中级人民法院知识产权技术咨询专家，中国生物物理学会会员，中国医药生物技术协会纳米生物技术委员会委员，青岛市药剂学会副主任委员。主持完成20多个新药立项与申报。在Nat Med,J Biomed Nanotechnol,Nanoscale,Curr Drug Metab,Int J Pharm等国际纳米载体及传输领域期刊上发表SCI论文19篇；申报中国发明专利15项。应邀为J Biomed Nanotechnol,Int J Pharm, Colloid and Surface B, JNanosci Nanotechnol等国际杂志审稿二十余篇次。 联系方式：0532-82031767，wangcheng@ouc.edu.cn 研究方向： （1）靶向给药系统的研究 （2）生物医用纳米载体材料的构建 （3）应用药物制剂的研究与开发 代表性论文： 1.Hongxia Li, Yun Li, Xuelian Xu, Mengyi Cong, Jiaqi Yin andCheng Wang*a,b.Preparation and Characterization of Novel Pimecrolimus Nanoparticles for Therapy of Allergic Conjunctivitis.J Biomed Nanotechnol.13,1106-11142017. 2.Ying hao, Jinrong Peng, Yaguang Zhang, Lijuan Chen, Feng Luo,Cheng Wang* and Zhiyong Qian*. Tumor Neovasculature-Targeted APRPG-PEG-PDLLA/MPEG- PDLLA Mixed Micelle Loading CombretastatinA4 for Breast Cancer Therapy.ACS Biomater Sci Eng.2017. DOI: 10.1021/acsbiomaterials.7b00523 3.Mengyi Cong,Zhongyu Wu,Xuelian Xu,Jiaqi Yin,Hongxia Li,Bo Zhuang,Cheng Wang*andXia Zhao*. Novel Oleyl Amine-modified Polymannuronic Acid Micelle Loading Tacrolimus for Therapy of Allergic Conjunctivitis.Int J BiolMacromol.104,862-8732017. 4.Cheng Wang1*, Biao Liu2+, Xuelian Xu1, Bo Zhuang1, Hongxia Li1, Jiaqi Yin1, Mengyi Cong1, Wei Xu3,4* and Aiping Lu2*Toward Targeted Therapy in Chemotherapy-resistant Pancreatic Cancer with A Smart Triptolide Nanomedicine Oncotarget. 7(7). 8360-722016 5.Bo Zhuang, Liang Du, Hongxia Xu, Xuelian Xu,Cheng Wang*,Yingfang Fan, Mengyi Cong, Jiaqi Yin, Hongxia Li and Huashi Guan*.Self-assembledMicelle Loading Cabazitaxel for therapy of Lung Cancer.Int J Pharm.499:146-155.2016. 6.Yingfang Fan, Bo Zhuanga,Cheng Wang*,Xuelian Xu, Wei Xu, Zhihua Lv*.Pimecrolimus micelle exhibits excellent therapeutic effect for Keratoconjunctivitis Sicca.Colloid and Surface B. 140 1-10.2016. 7.Cheng Wang*, Ying Shan, Jiuli Yang, Xuelian Xu, Bo Zhuang, Yingfang Fan and Wei Xu*. Inhibition of Cancer Angiogenesis Using Triptolide Nanoparticles .J Biomed Nanotechnol.11. 805-815 2015. 8.Chao Liang#, Baosheng Guo#, Heng Wu#, Ningsheng Shao, Defang Li, Jin Liu, Lei Dang,Cheng Wang, Hui Li, Shaohua Li, etc. Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference-based bone anabolic strategy.Nat Med.21(3):288-94,2015. 9.Cheng Wang*, Biao Liu, Jun Lu, Ge Zhang and Aiping Lu*. Strategiesfor Combination of Aptamer and Targeted drug delivery. J Nanosci Nanotechnol. 14(1): 501-512,2014 10.Cheng Wang, Chaofeng Long, Chengshi Xie, Xiaoxin Chen, Lan Zhang, Bingyang Chu, Yujun Wang, Feng Luo, and Zhiyong Qian* Two Novel Nanoscale Preparations of Micelle and Thermosensitive Hydrogel for Docetaxel to Treat Malignant Tumor.J Biomed Nanotechnol.9(3): 357-366,2013 靶向给药系统的研究 ;生物医用纳米载体材料的构建 ;应用药物制剂的研究与开发 [海洋信息资源服务平台] → 中国 → 山东 → 青岛 海洋生物医药业; 中国海洋大学 博士学位 2018-09-28 21:58:58